glp-1 drugs what is it How medications are transforming diabetes and weight loss treatment GLP-1 receptor agonists | How

The search strategy details are provided in Additional file 1: Table S1

doi: 10.1016/S0196-9781(00)00287-4 [DOI] [PubMed] [Google Scholar] 47.Tahara N, Tahara A, Honda A, et al

The highest price respondents would accept paying skewed lower among those who used to take a GLP-1 or are thinking of taking the drug

Cardiovascular death: 2.5% (Wegovy) vs 3.0% (placebo) Heart failure composite: 3.4% vs 4.1% All-cause death: 4.3% vs 5.2% A related study determined that 100 people with obesity would need to be treated for three years to prevent one major cardiovascular event

Adapted from: Ast J, Novak AN et al

Steven S, Hausding M, Krller-Schn S, Mader M, Mikhed Y, Stamm P, et al